Drug delivery from engineered organisms and nanocarriers as monitored by multimodal imaging technologies

In recent years, while the research budget and development times increased for different phases of drug development, the number of clinically approved new medicines declined. In fact, many promising drug candidates failed to demonstrate their full therapeutic potential <em>in vivo</em>....

Full description

Bibliographic Details
Main Authors: Daniel Calle, Duygu Yilmaz, Sebastian Cerdan, Armagan Kocer
Format: Article
Language:English
Published: AIMS Press 2017-03-01
Series:AIMS Bioengineering
Subjects:
Online Access:http://www.aimspress.com/Bioengineering/article/1322/fulltext.html